Data from animal studies shows that TRAIL may possibly contribute to the pathophysiology of cardiomyopathy [12,13], atherosclerosis [14,15], ischemic stroke [16], pulmonary hypertension [17] and abdominal aortic aneurysm [18]. This evidence concerns the gene TNFSF10 and atherosclerosis.